These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32093598)

  • 1. Complexes Formed via Bioconjugation of Genetically Modified TMV Particles with Conserved Influenza Antigen: Synthesis and Characterization.
    Gasanova TV; Koroleva AA; Skurat EV; Ivanov PA
    Biochemistry (Mosc); 2020 Feb; 85(2):224-233. PubMed ID: 32093598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.
    Petukhova NV; Gasanova TV; Stepanova LA; Rusova OA; Potapchuk MV; Korotkov AV; Skurat EV; Tsybalova LM; Kiselev OI; Ivanov PA; Atabekov JG
    Curr Pharm Des; 2013; 19(31):5587-600. PubMed ID: 23394564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level systemic expression of conserved influenza epitope in plants on the surface of rod-shaped chimeric particles.
    Petukhova NV; Gasanova TV; Ivanov PA; Atabekov JG
    Viruses; 2014 Apr; 6(4):1789-800. PubMed ID: 24755563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector.
    Pérez-Filgueira DM; Brayfield BP; Phiri S; Borca MV; Wood C; Morris TJ
    J Virol Methods; 2004 Nov; 121(2):201-8. PubMed ID: 15381357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
    Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
    Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine.
    Yao Y; Wang H; Chen J; Shao Z; He B; Chen J; Lan J; Chen Q; Chen Z
    Emerg Microbes Infect; 2019; 8(1):45-54. PubMed ID: 30866759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An influenza A virus vaccine based on an M2e-modified alphavirus.
    Krishnavajhala HR; Williams J; Heidner H
    Arch Virol; 2018 Feb; 163(2):483-488. PubMed ID: 29079954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin.
    Liu X; Guo J; Han S; Yao L; Chen A; Yang Q; Bo H; Xu P; Yin J; Zhang Z
    Vaccine; 2012 Oct; 30(46):6527-33. PubMed ID: 22959982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
    Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
    Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
    Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
    Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco mosaic virus coat protein: an elicitor of the hypersensitive reaction but not required for the development of mosaic symptoms in Nicotiana sylvestris.
    Culver JN; Dawson WO
    Virology; 1989 Dec; 173(2):755-8. PubMed ID: 2596036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
    Deng L; Ibañez LI; Van den Bossche V; Roose K; Youssef SA; de Bruin A; Fiers W; Saelens X
    PLoS One; 2015; 10(5):e0126650. PubMed ID: 25973787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementation of coat protein-defective TMV mutants in transgenic tobacco plants expressing TMV coat protein.
    Osbourn JK; Sarkar S; Wilson TM
    Virology; 1990 Dec; 179(2):921-5. PubMed ID: 2238482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.
    Ni Y; Guo J; Turner D; Tizard I
    Vaccine; 2017 Dec; 35(50):7026-7032. PubMed ID: 29102171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphology and stability changes of recombinant TMV particles caused by a cysteine residue in the foreign peptide fused to the coat protein.
    Li Q; Jiang L; Li M; Li P; Zhang Q; Song R; Xu Z
    J Virol Methods; 2007 Mar; 140(1-2):212-7. PubMed ID: 17140672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity purification of streptavidin using tobacco mosaic virus particles as purification tags.
    Negrouk V; Eisner G; Midha S; Lee HI; Bascomb N; Gleba Y
    Anal Biochem; 2004 Oct; 333(2):230-5. PubMed ID: 15450797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobamovirus coat protein CPCg induces an HR-like response in sensitive tobacco plants.
    Ehrenfeld N; Cañón P; Stange C; Medina C; Arce-Johnson P
    Mol Cells; 2005 Jun; 19(3):418-27. PubMed ID: 15995360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise Assembly of Genetically Functionalized Magnetosomes and Tobacco Mosaic Virus Particles Generates a Magnetic Biocomposite.
    Mickoleit F; Altintoprak K; Wenz NL; Richter R; Wege C; Schüler D
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37898-37910. PubMed ID: 30360046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity.
    Pérez Filgueira DM; Zamorano PI; Domínguez MG; Taboga O; Del Médico Zajac MP; Puntel M; Romera SA; Morris TJ; Borca MV; Sadir AM
    Vaccine; 2003 Oct; 21(27-30):4201-9. PubMed ID: 14505899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.